These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12575482)

  • 1. An introduction to statistical concepts for the analysis of EEG data and the planning of pharmaco-EEG trials.
    Schlattmann P
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():1-6. PubMed ID: 12575482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Planning of pharmacodynamic trials: I. Specificity and possible solutions. II. Stability considerations under placebo and interpretation of drug effects on EEG.
    Boeijinga PH; Calvi-Gries F; Demazières A; Luthringer R
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():17-26. PubMed ID: 12575484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical methods to estimate treatment effects from multichannel electroencephalography (EEG) data in clinical trials.
    Ma J; Wang S; Raubertas R; Svetnik V
    J Neurosci Methods; 2010 Jul; 190(2):248-57. PubMed ID: 20580744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Entropy analysis of the EEG background activity in Alzheimer's disease patients.
    Abásolo D; Hornero R; Espino P; Alvarez D; Poza J
    Physiol Meas; 2006 Mar; 27(3):241-53. PubMed ID: 16462011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative EEG in early Alzheimer's disease patients - power spectrum and complexity features.
    Czigler B; Csikós D; Hidasi Z; Anna Gaál Z; Csibri E; Kiss E; Salacz P; Molnár M
    Int J Psychophysiol; 2008 Apr; 68(1):75-80. PubMed ID: 18093675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Split-test Bonferroni correction for QEEG statistical maps.
    Vialatte FB; Cichocki A
    Biol Cybern; 2008 Apr; 98(4):295-303. PubMed ID: 18214522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method for detection of Alzheimer's disease using ICA-enhanced EEG measurements.
    Melissant C; Ypma A; Frietman EE; Stam CJ
    Artif Intell Med; 2005 Mar; 33(3):209-22. PubMed ID: 15811786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical problems in the analysis of comparative pharmaco-EEG trials.
    Abt K
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Mar; 12(2):228-36. PubMed ID: 461509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroencephalogram variability in dementia with lewy bodies, Alzheimer's disease and controls.
    Andersson M; Hansson O; Minthon L; Rosén I; Londos E
    Dement Geriatr Cogn Disord; 2008; 26(3):284-90. PubMed ID: 18841014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between disease severity and brain electric LORETA tomography in Alzheimer's disease.
    Gianotti LR; Künig G; Lehmann D; Faber PL; Pascual-Marqui RD; Kochi K; Schreiter-Gasser U
    Clin Neurophysiol; 2007 Jan; 118(1):186-96. PubMed ID: 17070733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on 'Analysis of electroencephalograms in Alzheimer's disease patients with multiscale entropy'.
    Tang B
    Physiol Meas; 2007 Dec; 28(12):L1-2; author reply L3-7. PubMed ID: 18057509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Information-based monitoring of clinical trials.
    Tsiatis AA
    Stat Med; 2006 Oct; 25(19):3236-44; discussion 3320-5, 3326-47. PubMed ID: 16927248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of EEG spectra and coherence following performance in a cognitive task in Alzheimer's disease.
    Hidasi Z; Czigler B; Salacz P; Csibri E; Molnár M
    Int J Psychophysiol; 2007 Sep; 65(3):252-60. PubMed ID: 17586077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate tests for the evaluation of high-dimensional EEG data.
    Hemmelmann C; Horn M; Reiterer S; Schack B; Süsse T; Weiss S
    J Neurosci Methods; 2004 Oct; 139(1):111-20. PubMed ID: 15351527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reassessment of trial perspectives from interim data--a critical view.
    Bauer P; Koenig F
    Stat Med; 2006 Jan; 25(1):23-36. PubMed ID: 16220517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues in designing flexible trials.
    Posch M; Bauer P; Brannath W
    Stat Med; 2003 Mar; 22(6):953-69. PubMed ID: 12627412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease modifying trials in Alzheimer disease: methodological and statistical issues.
    Andrieu S; Rascol O; Lang T; Grandjean H; Vellas B
    J Nutr Health Aging; 2006; 10(2):116-7. PubMed ID: 16554944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis and importance of statistical power and sample size in empirical scientific research].
    Klimek KM
    Wiad Lek; 2008; 61(7-9):211-5. PubMed ID: 19172834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EEG filtering based on blind source separation (BSS) for early detection of Alzheimer's disease.
    Cichocki A; Shishkin SL; Musha T; Leonowicz Z; Asada T; Kurachi T
    Clin Neurophysiol; 2005 Mar; 116(3):729-37. PubMed ID: 15721088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.